Following ATAI? Watch it free and get every rating change in a morning briefing, plus 3 copilot questions a day.

AtaiBeckley Inc. (ATAI)

Healthcare · Biotechnology · NasdaqGM

$7.18

0.00% todaydelayed

Where the Street stands

8 analysts rate ATAI Hold, with an average target 33.5% above today's price at $9.59.

These are third-party analyst opinions from named firms, not advice, and not a prediction. Earnings land in 9 days, which usually moves targets. How we score this

Analyst consensus

Hold

8 Wall Street analysts · Yahoo Finance (delayed)

Strong Buy

Buy

Hold

Sell

Strong Sell

StockRank Scoreskill-weighted ⓘ

Buy

9 firms currently rating it, weighted by track record.

The 7 firms with a track record here beat the S&P 43% of the time over 12 months.

Pro: see the crowd-vs-sharp split for ATAI

Avg price target

$9.59

+33.5% vs price

Target range

$7.45 to $16.00

12-month analyst targets

Next earnings

Thu, Aug 13

days

Date	Firm	Action	Rating
Jul 20, 2026	HC Wainwright & Co	▼ Downgrade	Buy → Neutral
Jul 17, 2026	Guggenheim	▼ Downgrade	Buy → Neutral

AtaiBeckley Inc. (ATAI)

8 analysts rate ATAI Hold, with an average target 33.5% above today's price at $9.59.

Price · last 12 months

Analyst rating actions